Medical Cannabis Market 2019 Forecast Outlook by Pharmaceutical Companies, Medical Applications, Cannabinoids Product, Cannabis Revenue Growth & Regional Landscape

Medical Cannabis industry is still in its nascent stage & will develop significantly in the coming years. Increasing use of marijuana in therapeutic applications such as pain management in neurology, cancer, HIV/AIDS, seizures, & nausea will drive the medical cannabis market growth

Dallas, United States - August 14, 2019 /MarketersMedia/ —

The research report on ‘global medical cannabis market’ provides a detailed market analysis with market share and major players operating in the market. The report also covers the comprehensive outlook of technology, product specification, production analysis, and product type with the help of some key factors such as gross margin, cost, and revenue. The global medical cannabis market report offers in-depth study market segmentation depending on several regions. The report also contains the qualitative and quantitative analysis of market players.

Get Research Insights @ Global Medical Cannabis Market Research Report

Global medical cannabis market size is valued at US$ 7.26 billion from US$ 56.70 billion at a recorded CAGR of 29.3% over the forecast period. Increasing countries approving the utilization of cannabis, increasing edible products, and rising Research & Development activities are fueling the global medical cannabis market growth. In addition, rising growth of therapies with cannabis expected to drive the global medical cannabis market growth.

The global medical cannabis market segmentation is done with the help of indication and geographical regions. By indication, the global medical cannabis market is divided into neurological disease, pain management, and many others. However, the pain management segment is accounted for the highest global medical cannabis market share of 60%, and it is likely to dominate its growth over the forecast period. Many patients with lasting disorders need medical cannabis and it is anticipated to boost the global medical cannabis market growth during the prediction period. Likewise, medical cannabis shows positive results in number of chronic diseases such as Alzheimer’s, Parkinson’s, and Epilepsy.

Medical Cannabis Market Size by Indication (Pain Management, Neurological disorders, and others) by Region and Forecast 2016 to 2026 @ https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Based on regional landscape, the global medical cannabis market is sub-segmented into the North America, Asia Pacific, Europe, MEA, and Central & South America. In between these, the North America region dominated for the highest global medical cannabis market share over the forecast period. However, Canada and United States are major regions which authorized medical cannabis with maximum number of consumers. Increased awareness about medical usage and its benefits in chronic disease are projected to rise rapidly than the North American market.

North America dominates the global medical cannabis market by contributing over 90% of total revenue, of which majority comes from the U.S. Additionally, legalization in Canada is expected to grow at a faster CAGR compared to the U.S., on account of growth phase of Canadian market. The total number of patients using medical cannabis in Canada has increased in the past few quarters with corresponding increase in the number of licensed producers. This increase in number of medical cannabis users has led to a spike in revenues for companies. Such prevailing dynamics in the Canadian market is expected to attract investors in the coming years.

The global medical cannabis market is highly competitive owing to the large number of leading competitors playing in the market. These players are trying to stand their position in the global as well as local market. They use several strategies such as merger & acquisition, new product launches, and R&D activities. Some top players operating in this market are Maricann Group, Inc., Aphria, Inc., ABcann Medicinals, GW Pharmaceuticals, Organigram Holding, Inc., and Lexaria Corp.

Make an Enquire to Buy This Report @ https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/864

Key Segments of the Global Medical Cannabis Market

Indication Overview, 2016-2026 (USD Billion)
• Pain Management
• Neurological Disease
• Others

Regional Overview, 2015-2025 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• Spain
• Italy
• Asia Pacific
• Australia
• New Zealand
• Central & South America
• Mexico
• Uruguay
• Middle East & Africa

Buy the report @ https://www.adroitmarketresearch.com/researchreport/purchase/864

Major points from Table of Contents:

Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Medical cannabis Market Overview, By Indication
Chapter 5. Key Country Market
Chapter 6. Company Profiles

Grasp advance knowledge on Global Medical Cannabis Industry through in-depth Blogs, White Paper & Infographics:

Access the Blog: “Medical Cannabis Helpful For Insomnia Patients

Across North America sleep disorders are very common now. Actually, many of the approximations are suggesting one in four Canadians suffering from insomnia, making it a common disorder of sleep.

Access the White Paper “All You Need To Know About Medical Cannabis

Recent United States Cannabis Research and Policy & Law Cannabis has validated health benefits since past few years. However, less than 6% of current studies on marijuana investigate its medical properties, periodicals to date specify that cannabis shows promise for the treatment of several diseases and symptoms. Though, patients with cancer and chronic pain, for ex. have been blocked from such benefits since the mid-20th century when government regulations were sanctioned that banned the sales, use, and distribution of cannabis due to its psychoactive properties.

About Adroit Market Research:

Adroit Market Research provide quantified B2B research on numerous opportunistic markets, and offer customized research reports, consulting services, and syndicate research reports. We assist our clients to strategize business decisions and attain sustainable growth in their respective domain. Additionally, we support them with their revenue planning, marketing strategies, and assist them to make decisions before the competition so that they remain ahead of the curve.

Contact Info:
Name: Ryan Johnson
Email: Send Email
Organization: Adroit Market Research
Address: 3131 McKinney Ave Ste 600 Dallas, TX 75204, U.S.A
Phone: +1 972-362 -8199
Website: https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

Source URL: https://marketersmedia.com/medical-cannabis-market-2019-forecast-outlook-by-pharmaceutical-companies-medical-applications-cannabinoids-product-cannabis-revenue-growth-regional-landscape/88907320

Source: MarketersMedia

Release ID: 88907320

Latest News

At global summit, Trump facing limits of go-it-alone stance

Aug 24, 2019

BIARRITZ, France — President Donald Trump arrived Saturday in France for an international summit with the leaders of the globe's economic powers as he confronts the consequences of his preference for going it alone, both in a sharply divided United States and an interconnected world. The meeting of the Group of Seven nations — Britain, Canada, France, Germany, Italy, Japan and the U.S. — in the beach resort town of Biarritz comes at one of the most unpredictable moments in Trump's White House tenure, with his public comments and decision-making increasingly erratic and acerbic of late. Trump, growing more isolated...

US stocks fall sharply as US-China trade war escalates

Aug 24, 2019

Stocks tumbled on Wall Street after President Donald Trump said he "hereby ordered" U.S. companies to consider alternatives to doing business in China. He also said he would respond to Beijing's latest tariff increase later Friday. The Dow Jones Industrial Average sank nearly 500 points after the president made the announcements on Twitter. Trump also said he was "ordering" UPS, Federal Express and Amazon to block any deliveries from China of the powerful opiod drug fentanyl. The stocks of all three companies fell as traders tried to understand what the implications for them were. The developments mark the latest escalation...

Global stocks higher ahead of US Fed chairman's speech

Aug 24, 2019

BEIJING — Global stock markets rose Friday after Wall Street declined ahead of a closely watched speech by the U.S. Federal Reserve chairman. Market benchmarks in London, Frankfurt, Shanghai and Tokyo all advanced. Investors are looking to Jerome Powell's speech Friday for signs of direction on interest rates after two regional Fed presidents said they see no need for a change. Investors expect a cut in September, the Fed's second in three months, to shore up U.S. economic growth amid a tariff war with Beijing and weakening global growth. "Markets seem very clearly positioned for some very dovish guidance from...

Trump, G-7 leaders to open summit focused on world economy

Aug 24, 2019

WASHINGTON — President Donald Trump and other leaders of the world's most industrialized nations will open their annual G-7 summit over the weekend by discussing the global economy. White House officials said Thursday that the session was added to Sunday's schedule at the last minute at Trump's request. Trump insists the U.S. economy is strong despite fears that a recession may be on the horizon. At the same time, global economic growth has slowed due to weakness in Germany, Europe's largest economy, and a pronounced slowdown in China, the world's second-largest economy, as it remains locked in a tense trade...

Report shows US deficit to exceed $1 trillion next year

Aug 24, 2019

WASHINGTON — The federal budget deficit is expected to balloon to more than $1 trillion in the next fiscal year under the first projections taking into account the big budget deal that President Donald Trump and Congress reached this summer, the Congressional Budget Office reported. The return of $1 trillion annual deficits comes despite Trump's vow when running for office that he would not just balance the budget but pay down the entire national debt. "The nation's fiscal outlook is challenging," said Phillip Swagel, director of the nonpartisan CBO. "Federal debt, which is already high by historical standards, is on...

Broaden News
Search

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Contact us: sales@managethenumbers.com

Subscribe to our newsletter!

Name

Email